7,0000 zł
-12,50% -1,0000 zł
SOPHARMA AD (SPH)

Sales revenues for October 2019

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Sales_revenues_for_October_2019_espi.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 62 / 2019
Date of issue: 2019-11-05
Short name of the issuer
SOPHARMA AD
Subject
Sales revenues for October 2019
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for October 2019 the Company recorded an increase in sales of 40% compared to the same month of 2018, incl. 30% increase in sales for the domestic market and 48% increase in export sales.
In the first ten months of 2019 the revenues from sales of production increased by 6% compared to the same period of 2018, incl. 4% decrease in domestic sales and 13% increase in export sales.
Annexes
File Description
Sales revenues for October 2019 espi.pdfSales revenues for October 2019 espi.pdf Sales revenues for October 2019

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2019-11-05 Ognian Donev Executive director
Źródło: GPW - komunikaty spółek (ESPI)
Dodałeś komentarz Twój komentarz został zapisany i pojawi się na stronie za kilka minut.

Jeszcze nikt nie skomentował tego artykułu - Twój komentarz może być pierwszy.

Nowy komentarz

Anuluj
Polecane
Najnowsze
Popularne
Przejdź do strony za 5 Przejdź do strony »

Czy wiesz, że korzystasz z adblocka?
Reklamy nie są takie złe

To dzięki nim możemy udostępniać
Ci nasze treści.